A Wholly Owned Subsidiary of
KRTL Holding Group Inc (OTC: KRTL)
A NEW GENERATION WHERE SCIENCE, NATURE, AND TECHNOLOGY MERGE.
We are eager to embark on this journey by uniting minds and developing groundbreaking answers to these areas, where science can truly shine.
A Bit About Us
KRTL Biotech Inc., a wholly owned subsidiary of KRTL Holding Group, Inc. (OTC: KRTL), is a research and development company that has obtained a Ministry of Food and Drug Safety (MFDS), formerly known as the Korea Food & Drug Administration (KFDA) approval for psilocybin and CBD research. KRTL Biotech is looking to collaborate and partner with universities and biotech companies to facilitate this venture.
Research and Development
Creating Strategic Partnerships
Unique Formulations
Global KRTL Brand
DRIVEN BY COLLABORATION
We at KRTL Biotech are looking to collaborate and partner with universities and biotech companies to facilitate this venture.
We Take Pride in Our Numbers
300+
SCI (Science Citation Index) Research Papers
100+
Years of Experience
$1-2B
Potential Product Market
22
Countries World Wide
2
Global Footprint
(Countries)
Our Partners
.png)
KRTL Biotech Inc. is focused on increasing its global footprint through its partners to create affiliations in multiple countries. What we are doing is establishing the KRTL brand, uniting the medical, psychological, and pharmaceutical world under a common goal, where ideas and technologies can be shared through affiliate companies.